HSAQ

Health Sciences Acquisitions Corporation 2 [HSAQ] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

HSAQ Stock Summary

In the News

07:00 28 Mar 2024 HSAQ

Health Sciences Acquisitions Corporation 2 Announces Closing of Upsized $160 Million Initial Public Offering, Including Full Exercise of the Underwriters' Over-Allotment Option

Health Sciences Acquisitions Corporation 2 (Nasdaq: HSAQ, the "Company" or "HSAC 2") announced today that it closed its initial public offering of 16,000,000 ordinary shares, which included the full exercise of the underwriters' over-allotment option. The ordinary shares were sold at $10.00 per ordinary share, resulting in total gross proceeds of $160,000,000.

HSAQ Financial details

Company Rating
Buy
Market Cap
149.23M
Income
-36.18M
Revenue
2.5M
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
25 Jan 2023
P/E
-31244.63
Forward P/E
-
PEG
-846.11
P/S
128.21
P/B
3688.47
P/C
-
P/FCF
-9.53
Quick Ratio
10.55
Current Ratio
10.77
Debt / Equity
0.14
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.08
EPS next Y
-
EPS next Q
-
EPS this Y
737.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-54.21%
EPS Q/Q
33.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
0%
Inst Trans
0%
ROA
-9%
ROE
-32%
ROC
-0.1%
Gross Margin
96%
Oper. Margin
-1048%
Profit Margin
-1012%
Payout
-
Shs Outstand
11.21M
Shs Float
0
-
-
-
-
Target Price
-
52W Range
9.41-13.8
52W High
+2.38%
52W Low
+47.89%
RSI
-
Rel Volume
1.68
Avg Volume
71.38K
Volume
119.61K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
25.21%
-
-
-
-
Beta
-
-
-
Volatility
1.16%, 1.16%
Prev Close
0%
Price
13.31
Change
23.24%

HSAQ Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K
Revenue per share
000
Net income per share
-0.01-0.02-0.15
Operating cash flow per share
-0.01-0.01-0.1
Free cash flow per share
-0.01-0.01-0.1
Cash per share
7.990.094.14
Book value per share
7.72-0.19-0.42
Tangible book value per share
7.727.73.7
Share holders equity per share
7.72-0.19-0.42
Interest debt per share
00-0.02
Market cap
259.71M204.36M163.93M
Enterprise value
257.68M202.61M163.75M
P/E ratio
-1.5K-563.37-68.59
Price to sales ratio
000
POCF ratio
-1K-750.33-103.8
PFCF ratio
-1K-750.33-103.8
P/B Ratio
1.66-51.84-23.61
PTB ratio
1.66-51.84-23.61
EV to sales
000
Enterprise value over EBITDA
-1.48K-534.93-59.87
EV to operating cash flow
-996.8-743.89-103.69
EV to free cash flow
-996.8-743.89-103.69
Earnings yield
00-0.01
Free cash flow yield
00-0.01
Debt to equity
000
Debt to assets
000
Net debt to EBITDA
11.684.630.06
Current ratio
18.0710.880.17
Interest coverage
024.678.92
Income quality
1.490.720.58
Dividend Yield
000
Payout ratio
000
Sales general and administrative to revenue
000
Research and developement to revenue
000
Intangibles to total assets
000
Capex to operating cash flow
000
Capex to revenue
000
Capex to depreciation
000
Stock based compensation to revenue
000
Graham number
1.220.281.18
ROIC
00.10.39
Return on tangible assets
00-0.04
Graham Net
7.71-0.23.69
Working capital
2.03M1.64M-1.44M
Tangible asset value
156.44M156.06M60.73M
Net current asset value
-3.57M-3.96M-7.04M
Invested capital
000
Average receivables
000
Average payables
07.6K189.16K
Average inventory
000
Days sales outstanding
000
Days payables outstanding
000
Days of inventory on hand
000
Receivables turnover
000
Payables turnover
000
Inventory turnover
000
ROE
00.090.34
Capex per share
000

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
00000
Net income per share
-0.03-0.08000
Operating cash flow per share
-0.04-0.03000
Free cash flow per share
-0.04-0.03000
Cash per share
4.994.14000
Book value per share
4.49-0.42000
Tangible book value per share
4.493.7000
Share holders equity per share
4.49-0.42000
Interest debt per share
0.01-0.01000
Market cap
135.85M163.93M367.94B460.71B469.09B
Enterprise value
135.12M163.75M367.92B460.69B469.08B
P/E ratio
-78.88-30.05-9.73K-9.56K-8.81K
Price to sales ratio
00316.1K503.5K1.12M
POCF ratio
-237.72-292.7-25.58K00
PFCF ratio
-237.72-292.7-25.52K00
P/B Ratio
2.21-23.613.69K5.15K5.89K
PTB ratio
2.21-23.613.69K5.15K5.89K
EV to sales
00316.08K503.49K1.12M
Enterprise value over EBITDA
-242.07-186.78-31.87K-35.56K-32.3K
EV to operating cash flow
-236.43-292.39-25.58K00
EV to free cash flow
-236.43-292.39-25.52K00
Earnings yield
0-0.01000
Free cash flow yield
00000
Debt to equity
000.020.020.14
Debt to assets
000.020.020.1
Net debt to EBITDA
1.320.21.431.110.52
Current ratio
0.610.1710.7710.085.13
Interest coverage
-6.372.75-11.36-13.77-15.87
Income quality
0.830.641.3100
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
007.099.2920.42
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00-0.0300
Capex to depreciation
00-0.4900
Stock based compensation to revenue
001.2800
Graham number
1.780.890.0100
ROIC
-0.010.09-0.08-0.14-0.16
Return on tangible assets
-0.01-0.02-0.07-0.1-0.11
Graham Net
4.483.69000
Working capital
-567.95K-1.44M117.82M107.73M88.72M
Tangible asset value
61.61M60.73M99.75M89.44M79.66M
Net current asset value
-6.17M-7.04M93.35M83.15M73.49M
Invested capital
000.020.020.14
Average receivables
0038K123.5K128.5K
Average payables
226.11K329.25K1.57M2.89M3.08M
Average inventory
00116K205K157.5K
Days sales outstanding
005.8816.8218.47
Days payables outstanding
005.66K5.02K6.91K
Days of inventory on hand
00474.55296.67300.73
Receivables turnover
0015.325.354.87
Payables turnover
000.020.020.01
Inventory turnover
000.190.30.3
ROE
-0.010.2-0.09-0.13-0.17
Capex per share
00000

HSAQ Frequently Asked Questions

What is Health Sciences Acquisitions Corporation 2 stock symbol ?

Health Sciences Acquisitions Corporation 2 is a US stock , located in New york of Ny and trading under the symbol HSAQ

What is Health Sciences Acquisitions Corporation 2 stock quote today ?

Health Sciences Acquisitions Corporation 2 stock price is $13.31 today.

Is Health Sciences Acquisitions Corporation 2 stock public?

Yes, Health Sciences Acquisitions Corporation 2 is a publicly traded company.

Something similar

Top by Market Cap
Similar Market Cap